We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Open-Irrigated Catheter Aids Treatment of Atrial Flutter

By HospiMedica International staff writers
Posted on 28 Mar 2016
A novel radiofrequency (RF) ablation catheter provides an elegant cooling platform for treating atrial flutter (AF), with robust handling capabilities.

The Blazer open-irrigated (OI) RF ablation catheter is indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, and RF ablation of sustained or recurrent type 1 AF in adult patients. More...
Contraindications include patients with an active systemic infection; those with a mechanical prosthetic heart valve; patients unable to receive heparin or an alternative anticoagulant; patients who have vena cava embolic protection filter devices; those who are hemodynamically unstable; and those who have myxoma or an intracardiac thrombus.

The ablation catheter features bidirectional steering, predictable trackability and torqueability, fine micromovement, and high tip stability and contact. A unique feature is Total Tip cooling, a technology to cool the catheter tip consistently during the procedure, thus improving the quality of the ablation lesion. The Blazer OI ablation catheter is intended for use with the Maestro 4000 RF Controller and the MetriQ irrigation pump, and is available with a range of tip curve styles, including standard, large, extra-long, and asymmetric. The Blazer OI ablation catheter is a product of Boston Scientific (Natick, MA, USA), and has been approved by the US Food and Drug Administration (FDA).

“The Blazer open-irrigated catheter is safe and effective for the ablation of atrial flutter," said Prof. Tom McElderry, MD, section chief of electrophysiology at the University of Alabama at Birmingham (UAB; USA), who participated in the BLOCk-CTI clinical trial of the device. “This newly approved ablation tool was built on the proven Blazer platform of therapeutic catheters and facilitates excellent maneuverability, consistent cooling, and stability during procedures.”

Cardiac ablation is a procedure that is used to correct structural problems in the heart by scarring or destroying tissue that triggers an abnormal heart rhythm, especially supraventricular tachyarrhythmias such as AF, atrial fibrillation, and atrial tachycardia. The low-risk procedure takes 2–4 hours and is most often performed in an electrophysiology or a cardiac catheterization lab. It is successful in about 90% of the people who have it.

Related Links:

Boston Scientific



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
Vessel Sealing Instrument
ERGOseal
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.